Protocol for rheumatoid arthritis complicated with cardiovascular damage treated with Guanxining tablet with a randomized controlled trial

BACKGROUND: Cardiovascular disease (CVD) is the main cause of death in patients with rheumatoid arthritis (RA). Apart from traditional cardiovascular risk factors, immune dysfunction and chronic inflammation of RA are also risk factors for complex cardiovascular damage. Although methotrexate (MTX) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Kai, Yang, Kepeng, Han, Tingfen, Sun, Qice, Zhu, Ming, Wang, Xinchang, Wang, Weijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474432/
https://www.ncbi.nlm.nih.gov/pubmed/37662776
http://dx.doi.org/10.1016/j.heliyon.2023.e19241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474432/
https://www.ncbi.nlm.nih.gov/pubmed/37662776
http://dx.doi.org/10.1016/j.heliyon.2023.e19241

Ejemplares similares